NCT04403555已完成2 期
The Efficacy of Ivermectin in COVID-19 Treatment
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 164
- 试验地点
- 1
- 主要终点
- The number of patients with mortality
研究概览
简要总结
Efficacy of Ivermectin in COVID-19 treatment
详细描述
Clinical Study Evaluating the Efficacy of Ivermectin in COVID-19 treatment
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All Adult Patients aging from 20 to 65 years-old with COVID-19 confirmed by pharyngeal swab PCR.
排除标准
- •Allergy or contraindication to the drugs used in the study.
- •Pregnant and lactating mothers.
- •Patients with cardiac problems.
研究组 & 干预措施
Ivermectin
Experimental
Ivermectin plus standard of care treatment Dose 2 tablets 12mg per day for 3 days
干预措施: Ivermectin (Drug)
结局指标
主要结局
The number of patients with mortality
时间窗: 1 month
Improvement of survival
次要结局
- The need for mechanical ventilation(1 month)
- Length of hospital stay(1 month)
研究者
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Tanta University
研究点 (1)
Loading locations...
相似试验
招募中
2 期
The Efficacy of Ivermectin in Larger Doses in COVID-19 TreatmentCOVIDNCT04351347Tanta University300
Unknown
不适用
Efficacy of Ivermectin in COVID-19COVIDNCT04392713Combined Military Hospital, Pakistan100
Unknown
2 期
The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)Covid19NCT04712279Corpometria Institute294
已完成
1 期
Efficacy of Ivermectin in COVID-19SafetySARS-CoV2 InfectionIvermectin PoisoningEffect of DrugNCT05076253Bangkok Metropolitan Administration Medical College and Vajira Hospital72
Unknown
3 期
Ivermectin Versus Standard Treatment in Mild COVID-19Covid19NCT04937569Assiut University1,644